# A Study of the Interaction of Other Drugs With TAK-279 in Healthy Adults

> **NCT06290050** · PHASE1 · COMPLETED · sponsor: **Takeda** · enrollment: 20 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** Midazolam
- **DRUG:** Repaglinide
- **DRUG:** TAK-279

## Key facts

- **NCT ID:** NCT06290050
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-03-29
- **Primary completion:** 2024-05-03
- **Final completion:** 2024-05-16
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2024-05-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06290050

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06290050, "A Study of the Interaction of Other Drugs With TAK-279 in Healthy Adults". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT06290050. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*